Institut Pasteur

A recognized public interest foundation, created by decree in 1887 on the initiative of Louis Pasteur, Institut Pasteur is now an internationally renowned biomedical research center. To carry out its mission dedicated to the fight against disease in France and around the world, the Institut Pasteur develops its activities in four areas: research, public health, training, and the development of research applications. 3,032 employees work on the campus in Paris.

A recognized world leader in the field of infectious diseases, microbiology, and immunology, the Institut Pasteur is dedicated to the study of living biology (molecules, cells, tissues, living organisms, microbe/host relationships). Its work focuses on:

• emerging infectious diseases (COVID-19, Ebola, Zika, etc.),
• antimicrobial resistance,
• certain cancers,
• neurodegenerative diseases (Alzheimer's, Parkinson's, etc.)
• and brain connectivity disorders (autism, depression, etc.).

To reinforce the excellence of its research, the Institut Pasteur has developed a high-level technological environment, such as in nano-imaging (cryomicroscopy, cryotomography, etc.) and computational biology and artificial intelligence.

This work, dedicated to improving our understanding of living organisms, also leads to the development and discovery of new means of diagnosis, treatment, and prevention. Since its creation, 10 researchers working at the Pasteur Institute have been awarded the Nobel Prize in Medicine, most recently in 2008 in recognition of their 1983 discovery of the human immunodeficiency virus (HIV) responsible for AIDS.
The Institut Pasteur is a member of the Pasteur Network, a global network of 32 members across five continents, united by common Pasteurian values, which contribute to the improvement of human health.